4-Hydroxy-2-(1-methyl-2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, 98%, 1g

Poudre de bismuth, min 99,5 %, maille environ, 100 g, emballage en verre

1-(3-Difluoromethylphenyl)ethanone, 96.00%, 100mg

6-(Bromomethyl)-4-chloroquinazoline, 95.0%, 250mg

2,6-Dibromoisonicotinonitrile, 95.0%, 10g

tert-Butyl 7-hydroxy-5-thia-2-azaspiro[3.4]octane-2-carboxylate, 97%, 100mg

2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one>97.0%(N)5g

4-Fluoro-5-methoxy-1H-indole, 97%, 250mg

4'-Formylbenzo-15-crown 5-Ether>98.0%(GC)100mg

(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate, 95.0%, 500mg

5-AMINO-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL HYDROCHLORIDE, 95.0%, 100mg

1-(4-Nitro-phenyl)-3-(5-nitro-thiazol-2-yl)-urea, 95.0%, 1g

2-(4-Amino-phenyl)-benzothiazol-6-ylamine, 97%, 1g